Trust + expectations
Why melasma advice is so inconsistent
Melasma has 131 registered trials and 4 with posted results — a rate of 6.8 percent against 43 to 49 percent for acne, psoriasis and rosacea.
- 6.8 percent reportedAgainst 43 to 49 percent elsewhere
- Light protection leadsVisible light matters, not only ultraviolet
- Expect fading, not clearingRecurrence is the condition, not a failure
On this pageHow thin the record actually is5
Quick answer
The bottom line
Melasma advice conflicts because the evidence underneath it is unusually thin: 131 registered trials have produced 4 with posted results, and total enrolment across all of them is 3,153 people. Expect slow, partial and reversible improvement, and treat daily high-protection sunscreen plus visible-light cover as the part that carries the most weight. Give any active twelve weeks, change one thing at a time, and be sceptical of any product promising to clear melasma, because nothing in the record supports that claim. Recurrence after sun exposure or pregnancy is the norm, not a treatment failure.
At a glance
Three things worth remembering
Section 01
How thin the record actually is
Melasma is not merely last on this table, it is an order of magnitude behind. Four completed studies with posted results is not enough to settle a single argument about which treatment sequence works best, which is why two dermatologists can give you different plans and both be reasoning honestly from what exists.[1][3]
Section 02
Why the money went elsewhere
Melasma is treated with off-patent ingredients. Hydroquinone, tretinoin, azelaic acid and tranexamic acid are all decades old and cheap to make, so no company recovers the cost of a large trial by proving one of them works. Industry funds 31 of the 131 melasma trials, against roughly two thirds of trials in acne, eczema and psoriasis.[1][2]
The condition also disproportionately affects people with more pigmented skin, and dermatology research has historically under-enrolled those groups. A condition that is common, distressing, chronic and commercially unrewarding is exactly the shape that falls through the gap.[1][5]
Section 03
What still holds up
Light protection is the most consistent finding across what evidence there is. Melasma responds not only to ultraviolet but to visible light, which ordinary sunscreens do not block. That is the argument for tinted mineral formulas containing iron oxides, and for hats and shade rather than sunscreen alone.[5][3]
Among the actives, hydroquinone remains the most established, usually short-term and under supervision because of the risk of paradoxical darkening with prolonged use. Azelaic acid, tretinoin and tranexamic acid all have supporting evidence, though the comparisons between them are weak. Procedures such as peels and lasers can help and can also worsen pigmentation, which is why they belong in experienced hands.[4][3]
Hormones matter. Pregnancy and combined contraception commonly trigger or worsen it, and it often fades after pregnancy without treatment. That alone explains many of the miracle-product stories.[3][5]
Section 04
A realistic plan given thin evidence
- Treat light protection as the foundation, every day, including indoors near windows and on overcast days.[5][3]
- Add one active and give it twelve weeks before judging. Changing several at once makes it impossible to know what helped.[3]
- Expect partial fading, not clearance. Improvement that holds while you keep protecting the skin is a good outcome here.[3][1]
- Plan for recurrence in summer and after hormonal change. That is the condition behaving normally.[3][5]
Section 05
Reading melasma claims with the gap in mind
When a product claims to clear melasma, ask what it was compared against and for how long. In a condition with four results-posted trials, a confident marketing claim is almost never backed by a trial you could go and read. Small uncontrolled studies of eight to twelve weeks are the norm, and melasma fluctuates naturally over that period.[1][3]
The thin evidence base is also a reason to avoid escalating quickly to aggressive procedures. Inflammation drives pigmentation, so a treatment that irritates can leave the skin darker than it started, and that pattern is well recognised even where trial data is missing.[3][5]
Your next step
Turn this into a practical plan
Choose the guide that best matches what you see. Each one starts with what to try, how long to wait and when to get help.